The panel referred the evidence of unlawful experimentation and fraud to the appropriate authorities.
It also ordered an immediate suspension of the compromised supply chain and required the medicine to be distributed through independently verified channels.
Helix disputed the allegations and began a legal defense.
Lorren Voss was removed from operational control while the formal investigation continued.
His removal did not erase the lives lost or restore the trust of frightened patients.
The families of the dead asked for records, explanations, and the ability to make decisions about how their loved ones would be remembered.
Some agreed to speak in public.
Others requested privacy.
Sepha supported both choices.
A memorial service was eventually held on Meridian, with names read only when families had given permission.
The chaplain who had lit Hamish’s lantern of return attended without his ceremonial robes.
He carried a simple lamp and placed it beside a row of empty chairs.
Each chair represented a person whose life had been taken by a preventable decision.
Hamish listened as the names were read and felt the old discomfort of being called a miracle.
He had survived by an accident of biology, through luck and the efforts of a doctor who had refused to surrender to an impossible prognosis.
The people named at the service had deserved care just as much as he had.
He told Sepha afterward that he wished his first bite had never become the beginning of a market.
She said the discovery itself had saved lives.
What happened afterward was the responsibility of those who chose to misuse it.
Hamish asked whether good discoveries always carried that risk.
Sepha said that every useful thing could become dangerous when people forgot who it was meant to serve.
Then she admitted that she had once been too certain her work would remain safe simply because its purpose was good.
That certainty was gone.
In its place she had learned to ask harder questions about ownership, access, and oversight.
The reformed antivenom program did not belong to a single corporation.
Independent laboratories could inspect the manufacturing standards, and clinics could verify each shipment without permission from a distributor.
A public fund supported small settlements unable to afford transport costs.
The new rules were slower to implement than the original optimistic announcements had been.
Some politicians complained that the system involved too much paperwork.
Sepha replied that paperwork was less expensive than funerals.
Imani helped design tracking equipment that could be repaired by local technicians rather than purchased repeatedly from distant suppliers.
